Product Information
MEPERIDINE 50 MG/5 ML SOLUTION is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1567 per ML under NDC 00054354563. Its NADAC has been published 320 times since Nov 28, 2013.
FDA first approved this application on Jan 30, 1985.
Strength
50 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054354563
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEPERIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA088744FDA Approved
1/30/1985
On Market Since
1/30/1985
Pharmacological Classes
Price Statistics
The NADAC for MEPERIDINE 50 MG/5 ML SOLUTION has been published 320 times since Nov 28, 2013, and over the history we have for it it has risen 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1567 per ML |
|---|---|
| All-time high | $0.1799 (Nov 15, 2017) |
| All-time low | $0.1108 (Nov 28, 2013) |
| 52-week high | $0.1592 |
| 52-week low | $0.1537 |
| Median price | $0.1558 |
| Average price | $0.1535 |
| Largest weekly change | +24.6% (May 21, 2014) |
| Weeks tracked | 320 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Meperidine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Meperidine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEPERIDINE 50 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for MEPERIDINE 50 MG/5 ML SOLUTION, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1567 per ML (NDC 00054354563), effective Sep 30, 2026.
How has the price of MEPERIDINE 50 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for MEPERIDINE 50 MG/5 ML SOLUTION has risen 41.4%. It has been tracked across 320 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEPERIDINE 50 MG/5 ML SOLUTION?
Since Nov 28, 2013, the NADAC for MEPERIDINE 50 MG/5 ML SOLUTION has ranged from a low of $0.1108 (Nov 28, 2013) to a high of $0.1799 (Nov 15, 2017), with a median of $0.1558 per ML.
Are there cheaper alternatives to MEPERIDINE 50 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of MEPERIDINE 50 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEPERIDINE 50 MG/5 ML SOLUTION?
MEPERIDINE 50 MG/5 ML SOLUTION (NDC 00054354563) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.